Determining the Causal Effect of Neurotrophic Tropomyosin Receptor Kinase Gene Fusions on Survival Prognosis for Adult Patients With Advanced Cancers

Emanuel Krebs, Nirupama Tamvada, Deirdre Weymann, Howard J Lim, Stephen Chia, Cheryl Ho, Dean A Regier · 2026

Read Determining the Causal Effect of Neurotrophic Tropomyosin Receptor Kinase Gene Fusions on Survival Prognosis for Adult Patients With Advanced Cancers by Emanuel Krebs, Nirupama Tamvada, Deirdre Weymann, Howard J Lim, Stephen Chia, Cheryl Ho, Dean A Regier (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13668040.txt.

Description

Emanuel Krebs and co-authors ask whether a rare gene fusion itself shortens life in advanced cancer. Their 2026 paper studies NTRK fusions, which some tumors carry. Doubt about their meaning clouds care choices and trial reading. The team mimicked a randomized trial in a large US clinic-genomic database.

They matched 73 fusion-positive patients one-to-one with similar patients lacking the change, inside seven tumor groups. Patients who got targeted fusion drugs were left out. Fusion carriers lost about fifty days of expected survival in the first year, a clear gap. The gap held at two and three years but faded by five. The authors call the fusion a true poor-outlook sign when no targeted drug is used.

Catalog record

CREATOREmanuel Krebs, Nirupama Tamvada, Deirdre Weymann, Howard J Lim, Stephen Chia, Cheryl Ho, Dean A Regier
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13668040

Browse the full library · About the Tower of Babel